Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity.A group that ...
Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.
Metsera’s GLP-1 peptide has a long half-life, meaning it could be administered once a month. The company is ready to scale up ...
Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s ...
Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more
Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells ...
Weight-loss drugs aren’t just slimming waists; they create a $100 billion market opportunity. With plenty up for grabs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback